The cell surface marker CD133 (prominin-1), initially recognized as a surface marker for hematopoietic and neural stem cells [58, 59], has been successfully used to enrich for cells with stem cell or cancer-initiating characteristics from multiple organs [60–64]. This evidence concerns the gene PROM1 and cancer.